Rapid and Simple Paper Strip Test for the Multiplexed Detection of Gastrointestinal Pathogens at the Point-of-Need GoDx Product Summary: This Phase 1 project will demonstrate the feasibility of developing a paper strip device for rapid (<30 minutes) and simple multiplexed detection of a 7 gastrointestinal (GI) pathogens that cause diarrheal disease. The pathogens include C. Difficile (for the U.S.) and the 6 pathogens (Cryptosporidium, Giardia lamblia, Rotavirus, Shigella, Enterotoxigenic Escherichia coli (ETEC), and Enteroaggregative Escherichia coli (EAggEC)) commonly found in the developing world. A highly innovative, simple and low cost sample preparation and concentration will be carried out using hollow silica microspheres that efficiently capture total nucleic acids and floats to the air- liquid interface for collection. The captured nucleic acids will be released onto the center of a novel star shaped lateral flow device for multiplexed detection of pathogens. Analytical validation will be conducted including assessments of reproducibility (%CV <10), sensitivity (> 90%), specificity (>90%), limit of detection (10,000 cells/g stool), and dynamic range (3 logs) on pathogen spiked-in samples or pathogen infected samples. The accuracy of the test will be benchmarked using current gold standard diagnostic methods, such as microscopy, culture, PCR and ELISA kit and the FDA-approved Luminex Gastrointestinal Pathogen Panel (GPP) bead detection, and Biofire/Biomerieux GI Panel.

Public Health Relevance

Rapid and Simple Paper Strip Test for the Multiplexed Detection of Gastrointestinal Pathogens at the Point-of-Need GoDx Project Narrative Diarrheal disease kills 1.9 million people worldwide ever year, mostly children in the developing world in resource-limited settings. An effective low-cost test to identify the pathogens causing persistent diarrhea may help guide prompt and appropriate treatment and reduce antimicrobial resistance from antibiotic overuse. We are developing a simple, rapid and sensitive paper strip test to identify gastrointestinal pathogens that cause diarrheal disease without the use of expensive instrumentation at the point-of-need.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43TR001912-01A1
Application #
9348091
Study Section
Special Emphasis Panel (ZRG1-IMST-L (10)B)
Program Officer
Portilla, Lillianne M
Project Start
2017-04-15
Project End
2018-04-14
Budget Start
2017-04-15
Budget End
2018-04-14
Support Year
1
Fiscal Year
2017
Total Cost
$299,726
Indirect Cost
Name
Godx, Inc.
Department
Type
Domestic for-Profits
DUNS #
078457602
City
Irvine
State
CA
Country
United States
Zip Code
92620